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Highlights 
 A systematic review and meta-analysis were conducted to determine the reference range 
of 8-OHdG in the EBC 
 The null hypothesis that the 8-OHdG levels in EBC are consistent across the different 
control groups was strongly rejected 
 The between-study variability was very high; it was mainly confounded by the 
analytical method and completely dominated the within-studies variability 
 Smoking was evidenced as a potential determinant of 8-OHdG inter-individual 
variability but only when immunochemical analysis was used. 
 The estimated reference values should be considered preliminary, as they are based on 
a limited number of studies, mostly of moderate to low quality of evidence.  
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 Further research is necessary to standardize EBC sampling, storage and analytical 
methods. 
Abstract 
In the field of engineered nanomaterials (ENMs) and other airborne particulate exposure 
biomonitoring, circulating oxidative stress biomarkers appear promising. These biomarkers 
could be monitored in different biological matrices. Exhaled breath condensate (EBC) enables 
their measurements in the respiratory tract, without affecting airway function or creating 
inflammation. The 8-hydroxy-2-deoxyguanosine (8-OHdG) was found increased in the EBC of 
ENM-exposed workers.  Our objectives were to assess the reference range of 8-OHdG in the 
EBC and to identify determinants of its inter- and intra-individual variability. The meta-analysis 
was stratified by analytical method (chemical versus immunochemical analysis) and resulted in 
a between-study variability over 99% of the total variability. The between-study variability 
completely dominated the within-studies variability. By using a mixed model with study ID as 
a random effect rather than a meta-regression, only smoking was evidenced as a potential 
determinant of 8-OHdG inter-individual variability, and only when immunochemical analysis 
was used. To our knowledge, this is the first meta-analysis aimed at estimating reference values 
for 8-OHdG in the EBC. The estimated values should be considered preliminary, as they are 
based on a limited number of studies, mostly of moderate to low quality of evidence. Further 
research is necessary to standardize EBC sampling, storage and analytical methods. Such a 
standardization would enable a more accurate estimation of the reference ranges of the 8-OHdG 
and potentially other biomarkers measurable in the EBC, which are essential for a meaningful 
interpretation of the biomonitoring results.  
Keywords: lung inflammation; 8-hydroxy-2'-deoxyguanosine; occupational exposure; 
inhalation; biomonitoring 
 
1. Introduction 
Despite a paucity of epidemiological data regarding the health effects of engineered 
nanomaterials (ENMs) (Guseva Canu et al. 2018), both human and animal experiments reported 
that ENMs elicited activation of inflammatory and oxidative stress responses that could be 
monitored in different biological matrices as preclinical alterations (Bencsik et al. 2018; Schulte 
et al. 2019). Such preclinical alterations may function both as indicators of early effects before 
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clinical manifestations may occur and as indirect markers of exposure, although with a low 
specificity for ENMs (Schulte et al. 2019). Several reports suggested the usefulness of 
biological monitoring to survey populations exposed to chemical hazards (Boogaard et al. 2011; 
Louro et al. 2019), in particular to emerging hazards with unknown toxicity, such as ENMs 
(Bergamaschi et al. 2015; Schulte et al. 2018; Schulte et al. 2016). Biomarkers of early adverse 
effects appears relevant to anticipate and indicate some negative health effects consequences 
that might accompany increasing production and use of ENMs in unprotected areas. They 
reflect early modifications preceding progressive structural or functional damage, but can be 
completely reversible upon the removal from the exposure of concern. 
Oxidative stress (OS) is considered an important component in the toxicological pathways, 
leading to the expression of virtually all diseases (Frijhoff et al. 2015). OS results from an 
imbalance between the production of reactive oxygen species (ROS, which are natural by-
products of oxygen metabolism) and the antioxidant defensive capacity of an organism (Sies 
2015). Excessive production of ROS suppresses antioxidant capacity in vivo, damaging DNA, 
lipids, proteins, and free amino acids (Frijhoff et al. 2015). Because of the highly reactive nature 
of ROS and, in turn, their short half-life, measures of OS usually rely on the assessment of these 
products of oxidizing reactions (Chamitava et al. 2018). Despite a vast number of analytical 
methods developed to measure the extent and to understand the nature of oxidative stress 
biomarkers, their measurements in routine remains difficult. Moreover, predictive value of 
circulating OS biomarkers remains poorly understood and positive associations between health 
effects and some OS biomarkers still need to be validated (Frijhoff et al. 2015; Kander et al. 
2017; Shih et al. 2019). Analytical validation is a prerequisite in biomarker development and 
research (WHO 2001). Furthermore, the assessments of the inter- and intra-individual 
biomarker variability, the kinetics of biomarker excretion, and the background biomarker 
values in the general population is required. The latter corresponds to the 95th percentile value 
of a given biomarkers in the general healthy population, while the reference range corresponds 
to the prediction interval between which 95% of biomarker values measured in the reference 
population fall into.  As most biomarkers have a skewed instead of normal distribution, the 
reference ranges are presented as geometric mean and associated geometric standard deviation 
(GSD). Today, none of OS biomarkers has been validated in a large prospective cohort and 
very few have established reference ranges (Koutsokera et al. 2008). The absence of reference 
values in biological matrices other than blood is particularly salient. Nevertheless, the choice 
of appropriate biological matrix for a biomarker validation for non-invasive biological 
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monitoring in occupational setting has a paramount importance. For ENMs, the respiratory tract 
is the primary route of exposure in occupational settings, thus the respiratory system plays a 
central role in the toxicokinetic and toxicodynamic profile of ENMs (Bencsik et al. 2018; 
Schulte et al. 2019). ENMs may enter other human organs and generate toxicity after they are 
absorbed into the bloodstream through the respiratory systems (Mu et al. 2014). As the 
persistence of inflammation and oxidative stress in the lungs may have a “systemic” impact on 
the body, other matrices could be relevant for assessing systemic inflammatory and oxidative 
stress response (Beard et al. 2018; Kuijpers et al. 2018; Schulte et al. 2019). Blood usually 
represented an ideal matrix for many chemicals due to its interaction with the organism and its 
chemical equilibrium with organs and tissues. However, blood has an important disadvantage 
of requiring an invasive sampling and being challenging to use in occupational or 
environmental settings for oxidative stress measurement. Instead, urine appears as a more 
suitable matrix, with reduced sample manipulation - no severe pre-treatment or pre-purification 
steps, and thus a reduced risk of pre-analytical artifacts compared to blood (Andreoli et al. 
2011). Therefore, the exhaled breath condensate (EBC) has been recently proposed as a non-
invasively collected biological matrix to detect biomarkers of oxidative stress reflecting  
inflammation in the cell  (Lee et al. 2015; Pelclova et al. 2016a; Pelclova et al. 2017; Vlaanderen 
et al. 2017; Wu et al. 2014). Consequently, EBC is the preferential matrix for establishing the 
reference ranges for the most promising OS biomarkers for non-invasive biological surveillance 
of ENM-exposed workers.  
One of the most interesting oxidative stress biomarker concerns DNA damages. During the 
enzymatic DNA repairing process, some oxidized products are excreted from the cell without 
any further metabolism. One of them is 8-hydroxy-2-deoxyguanosine (8-OHdG), generated 
following the repair of the guanosine, the most oxidized nucleobase in ROS-mediated DNA 
damages guanosine (Kasai 1997). Increase in 8-OHdG level measured in the EBC was 
frequently reported among ENM-handling workers (Schulte et al 2019), but the absence of the 
reference range for this biomarkers precludes any meaningful interpretation of this finding. 
The objectives of this study were to estimate the reference range of 8-OHdG in the EBC of the 
healthy non-smoking adults and to identify the determinants of its inter- and intra-individual 
variability.  
2. Methods 
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To achieve our objectives in a cost-effective way, we designed and conducted a systematic 
review and meta-analysis for several biomarkers in two matrices: urine and EBC. The protocol 
has been developed according to recommendations from Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) (Moher et al. 2009; Moher et al. 2015) and 
registered with the International Prospective Register of Systematic reviews (registration 
number CRD 42019124621). This study is focused on 8-OHdG measured in the EBC. 
 
2.1. Literature search 
Searches were conducted for literature published since journal inception and up to March 26 
2019 in the following bibliographic electronic databases: The Cochrane Central Register of 
controlled Trials (CENTRAL, Cochrane Library), EMBASE, PubMed, and Web of Science. 
The search strategy was adapted specifically for each electronic database used. To enlarge the 
documents search and ensure a systematic review as exhaustive as possible, a combination of 
the MeSH (Medical Subject Headings) terms from the PubMed database Emtree terms from the 
EMBASE database and free text words was used for each of biomarkers considered. This 
strategy allowed expanding this review to additional biomarkers by adding terms corresponding 
to them. The complete search strategy (exemplified by the search in PubMED and EMBASE 
databases) is available as a supplementary digital content 
(https://www.doi.org/10.16909/dataset/17) 
Original research studies in healthy human participants (aged 18+, no known disease) 
measuring the biomarkers in EBC written in English or French were included. The studies 
without quantitative data, non-human, in -vitro studies, reviews, correspondence, conference 
papers, expert opinions and editorials, as well as abstracts without full text were excluded. 
Furthermore, we also excluded studies where EBC collection device failed to meet American 
Thoracic Society and European Respiratory Society methodological recommendations 
(Horvath et al. 2005). 
Two reviewers (MH and YS) independently performed a first screening of titles and abstracts 
retrieved during the searches, using Rayyan software (Ouzzani et al. 2016). Abstracts with 
insufficient information with regard to the inclusion and exclusion criteria were downloaded in 
the EndNote software for a full-text screening. The same reviewers independently assessed each 
article. Disagreements on the inclusion/exclusion of studies between two reviewers were 
discussed and solved by consensus; when necessary a third reviewer (IGC) was consulted to 
reach consensus.  
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2.2. Data extraction 
To gather the essential information according to our research objectives, we developed a 
standardized data extraction form, which was pre-tested by two reviewers (MH and MG) and 
validated by a statistician (PW). The information as follows: first author name, publication time, 
study type, analytic method, the sample time, the number of participants, the gender, the mean 
age, the mean BMI, their smoking status, season, occupation, pregnancy, diet, vitamin, exercise, 
outcomes, was considered of interest and extracted by two independent reviewers (YS and 
MH). When data on several subgroups were available in a given paper, all subgroup-specific 
data were extracted. In a second round, we excluded all subgroups selected based on a disease 
status (e.g. diabetics) and all subgroups selected based on an exposure status (e.g. welders). If 
data on the same population was reported at different moments (e.g. different seasons), only the 
data at inclusion were included. Finally, in a third round, duplicate data were excluded (e.g. the 
same control population was reported in more than one study). All quantitative data extracted 
were cross-checked by a statistician. 
 
2.3. Quality assessment 
Specifically for purpose of this review, we developed a checklist of quality assessment criteria, 
which was reviewed by the experts in epidemiology, biostatistics, toxicology, biomonitoring, 
chemistry, and pharmacology. . This checklist included four domains: (i) quality of the study 
sample, (ii) quality of study design and risk of bias, (iii) technical and analytical quality (i.e., 
quality of biological sample collection and conservation and of the laboratory analyses, and (iv) 
quality of the data processing, analysis and result reporting. Each domain can be assessed 
separately, based on a number of objective criteria (Supplementary material Table S1), and 
graded by assigning a discreet sub-score value. The resulting sub-scores values can be further 
summarized in a final score for each study, as recommended in the GRADE guidelines (Guyatt 
et al. 2008). The total quality scores ranged between 9 and 27. Quality scores lower or equal to 
13 corresponded to a low quality of evidence; scores between 14 and 19 to a moderate quality 
of evidence, and scores higher than 20 to a high quality of evidence. The quality assessments 
of the included studies was performed by two reviewers (YS, MH) independently, the 
discrepancies were solved through discussion and the quality assessment by a third reviewer 
(IGC).  
 
2.4. Statistical analysis 
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 As primary research outcome, we analyzed the baseline values of biomarkers measured 
in original studies of healthy non-smoking adults in view of establishing the reference ranges 
using meta-analysis. Values of biomarkers selected, in particular urinary biomarkers, were 
generally log-normally distributed (Graille et al. (submitted)), therefore for EBC, we also 
computed geometric means (GM) and geometric standard deviations (GSD) as the basis of the 
meta-analysis. GM and GSD computing accounted for the heterogeneity of original data 
reported. If the data were reported in terms of arithmetic means (AM) and standard deviations 
(SD),  the arithmetic mean and the standard deviation of the log-transformed measurement of 
the biomarker was calculated as: 𝑚𝑢𝐿 = ln⁡(𝐺𝑀) and 𝑠𝑑𝐿 = ln(𝐺𝑆𝐷) , respectively.  
If the variability parameter was given as the standard error of the mean (SEM), we first 
computed SD as a product of SEM and of square root of the number of subjects on which the 
SEM computed: 𝑆𝐷 = 𝑆𝐸𝑀⁡. √𝑁.  
Then,  𝑚𝑢𝐿 = ln(𝐴𝑀) − 0.5 ln (1 +
𝑆𝐷2
𝐴𝑀2
) 𝑎𝑛𝑑⁡⁡𝑠𝑑𝐿 = √ln⁡(1 +
𝑆𝐷2
𝐴𝑀2
) 
 If the data were reported in terms of GM and 95%CI, we assume that the lower (LCL) 
and upper (UCL) confidence limits correspond respectively to 
𝐿𝐶𝐿 = exp (muL − 1.96
sdL
√𝑁
⁡) ⁡⁡⁡⁡⁡𝑎𝑛𝑑⁡⁡⁡⁡⁡⁡⁡⁡⁡𝑈𝐶𝐿 = exp (muL + 1.96
sdL
√𝑁
).⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡Thus, 
muL = (ln(LCL) + ln⁡(UCL))/2⁡⁡⁡and⁡⁡⁡𝑠𝑑𝐿 = (ln(UCL) − ln⁡(LCL)).√𝑁/(Φ(0.975) − (Φ(0.025)), 
where Φ is the cumulative distribution of the standard normal distribution. 
 If the data were reported in terms of AM and 95%CI, we assume that the lower (LCL) 
and upper (UCL) confidence limits correspond respectively to  
𝐿𝐶𝐿 = 𝐴𝑀 − 1.96
𝑆𝐷
√𝑁
⁡)⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡𝑎𝑛𝑑⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡𝑈𝐶𝐿 = 𝐴𝑀 + 1.96
𝑆𝐷
√𝑁
).⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡ 
Thus,   AM =
LCL+UCL
2
⁡⁡and⁡⁡𝑆𝐷 = (UCL − LCL). √𝑁/(Φ(0.975) − (Φ(0.025)) 
From AM and SD, we applied the formulas cited above. 
 If the data were reported in terms of quartiles (denoted Q1 and Q3 and/or median, we 
applied following formulas: 
muL = (ln(𝑄1) + ln(Q3))/2⁡⁡⁡and⁡⁡⁡𝑠𝑑𝐿 = (ln(Q3) − ln⁡(Q1))/(Φ(0.75) − (Φ(0.25)),⁡   
with muL = ln(𝑚𝑒𝑑𝑖𝑎𝑛), which allowed an internal check of the statistics. 
When neither SD, GSD, IQR nor IC were reported, making it impossible to compute standard 
errors on the geometric (or arithmetic scale), we excluded the studies from the meta-analysis. 
Before computing GM and GSD, we converted all data to the same units, (pg/mL for 8-OhDG 
in EBC). The analytical methods used were stratified by main quantification methods into 
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immunochemical techniques and chemical analytical methods (in these papers liquid—
chromatography coupled to mass spectrometry in tandem- LC-ESI-MS/MS, and ELISA) and 
data analyzed separately. For each biomarker of interest, other independent variables may be 
considered depending on the number of study groups and the available information in the 
studies. 
According to standard practice in meta-analysis (Deeks et al. 2017), the first step is to represent 
the data as forest plots including the I-square that estimates the percentage of the between-study 
heterogeneity. If the latter is very large, this means that the between-study heterogeneity is 
much larger than the between-subject heterogeneity and any attempt of obtaining a reference 
value for individual subjects will not be valid. 
 We used STATA, version 16 software for data management and statistical analyses. 8-OHdG 
measured in EBC was the first biomarker of interest we analyzed according to this protocol. 
3. Results 
3.1. Study selection 
The application of the literature research string in four databases resulted in 19421 records 
(Figure 1). After removal of duplicates and selection of the studies where EBC was collected 
for analyses, 893 records remained. From these records, 590 were excluded based on the title 
and abstract reading. Among the remaining 303 records, 17 included 8-OHdG measurements 
in EBC. After reading these studies, eight were included into the narrative description and six 
into quantitative synthesis. The study by (Fireman Klein et al. 2019) was excluded because only 
the arithmetic mean was reported - no variability (SD GSD, IC IQR) indicated. The control 
group in (Pelclova et al. 2016b) and in (Pelclova et al. 2016c) was identical and was therefore 
not included twice. The other study- sub-groups presented in Pelclova articles were groups with 
various occupational exposures and were therefore not included.  
3.2. Descriptive results 
Among the eight studies included into the systematic review, five (62.5%) were of moderate 
quality andthree of low quality of evidence (Supplementary material, Table S2). Among the six 
studies included in the meta-analyses five were analyzed chemically and one by 
immunochemical methods. Table S2 summarizes all the included studies and provides detailed 
information on their respective quality, including sub-score values for  each of four domains 
considered. 
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3.3. Meta-analysis results 
We split the six study samples into eight subgroups according to the analytical method used 
and according to the smoking status of participants (smokers/passive smokers or non-smokers). 
Five subgroups were not occupationally exposed to dust or other hazards and were analyzed 
using the chemical method. The three other sub-groups were also unexposed but analyzed using 
the immunochemical method. The coefficient of variation was between 22% and 41%. No study 
group was excluded on this basis. Figure 2 presents a forest plot of 8-OHdG concentrations in 
EBC for different subgroups, stratified by analytical method. For both analytical methods the 
between study variability was very high (over 99% of the total variability) and completely 
dominated the within-studies variability. By consequence, a meta-regression of all the study 
groups mostly reflected differences between studies rather than any actual effect of 
determinants considered. For that reason, a mixed model with study ID as a random effect 
appeared a more relevant analysis model. Nevertheless, due to small number of included studies 
quantitative statistical analysis of determinants were very limited. For instance, the effect of sex 
could not be assessed, as it was completely confounded with the analytical method (data not 
shown). Stratified analysis of the 8-OHdG measured in EBC using chemical analytical method 
showed no major difference between the non-smoking populations versus mixed populations 
or smokers (Figure 3a). In contrast, when the 8-OHdG was measured in EBC using 
immunochemical analytical method, the group of current smokers had a higher 8-OHdG GM 
or concentrations than the non-smokers and the passive smokers (Figure 3b).  
4. Discussion  
To our knowledge, this study is the first focusing on the 8OHdG levels measured in the EBC 
to estimate the reference values. This study was limited by a low number of original research 
studies and by the relatively poor quality of evidence gathered from these studies. A third of 
the studies provided low evidence, due to numerous methodological, analytical and data 
reporting drawbacks. We found that between-study differences were mainly confounded by the 
analytical method. Noteworthy, all studies originated from only two laboratories (the lab of 
Doruk et al. using ELISA and reporting much higher 8-OHdG levels) and the Czech laboratory 
using LC-ESI-MS/MS. Since these two analytical methods have different sensitivity and 
specificity (Carraro et al. 2010), the interpretation of these results is challenging.  The LC-ESI-
MS/MS has a high performance in terms of sensitivity and specificity and provides reproducible 
results. However, it requires expensive instruments. The ELISA depends on the commercial 
kits used and is less reproducible than the chemical analytical method. Therefore the analysis 
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should be done in triplicate (Falk et al. 2000). Furthermore, the kit used by Doruk only covers 
the range 0.125-10 ng/mL, which is two orders of magnitude less sensitive than the LC-MS/MS, 
covering pg/ml ranges. 
Despite a limited number of strata in this meta-analysis, our null hypothesis that the 8-OHdG 
levels in EBC are consistent across the different control groups was strongly rejected. As no 
details were given as to how the controls were selected, one can only speculate as to why this 
is so. The standard deviation (expressed in percent of the mean: the coefficient of variation) 
varied between 20% and 40% of the mean which seems correct and in line with within-study 
GSDs varying between 1.24 and 1.48. Most of the between-subgroup variability was due to the 
difference between the two laboratories. However even within the laboratories the between 
study variability exceeded by far this within-study variability leading to I-square values over 
95%. Thus, the presented graphs give indications of the between-study variability within 
analytical method, whose origin is mainly unknown (e.g. population selection, day-to-day lab 
variability), but cannot claim to yield reference values for individual subjects. As gender was 
completely confounded with this difference, no inference can be done on its effect. With respect 
to smoking, non-smoking subgroups showed significantly lower level of 8-OHdG in the single 
study using ELISA. No difference according to smoking could be shown in the different studies 
of the Czech groups.  
EBC could represent an ideal biological matrix for monitoring and screening of healthy 
individuals for possible early respiratory diseases because it enables noninvasive assessment of 
biochemical and inflammatory parameters in the airways. However, it still has some limitations 
that may explain the weakness of the database in our meta-analysis. The EBC use for analytical 
purposes is relatively recent and currently available analytical techniques are limited in 
sensitivity and specificity. Therefore, analysis of low concentration of OS biomarkers is a 
hurdle which partially explains the variability in reported values. Likewise, no fully validated 
method for calculating dilution of respiratory droplets is available (Dodig and Cepelak 2013). 
An ideal dilution factor would have a known and stable plasma concentration and high diffusing 
capacity through the cellular membrane and would not be a product of the respiratory tract 
(Effros et al. 2003; Konstantinidi et al. 2015). In addition, the levels of oxidative biomarkers 
such as the 8-OHdG have shown circadian variations (Kanabrocki et al. 2002) and can be 
affected by certain food, drinks or medications (Fan et al. 2000; Halliwell 2002; Kasai et al. 
2001) and they are not taken into account and descripted in the studies. These still unresolved 
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questions, for which we had no quantitative data, could constitute confounding factors and limit 
our analysis of the inter- and intra-individual variability in the 8-OHdG levels.  
Standardization of EBC analysis still requires international collaborative effort. In 2005, the 
American Thoracic Society (ATS)/ European Respiratory Society Task Force based on the 
consensus of the expert panel published some recommendations for analysis of the EBC 
(Horvath et al. 2005) . They provide guidelines on areas of uncertainties in the expectation of 
optimizing future researches in their methodologies, of implementing consistent protocols and 
standards across research laboratories and encouraged research in this new field (Wallace and 
Pleil 2018). Once the EBC sampling and storage methods are standardized, along with the 
analytical methods, their implementation in a large representative sample of general population 
would enable a more accurate estimation of the reference ranges of the 8-OHdG and potentially 
other biomarkers measurable in the EBC.  
5. Conclusion  
This first attempt to determine the reference values for the 8-OHdG in the EBC using meta-
analysis faced with some complex challenges. The lack of standardization of the methods 
currently used and the diversity of sample collection devices/ techniques impacted considerably 
our meta-analysis. As result, the between study variability was over 99% of the total variability 
and completely dominated the within-studies variability. The small number of studies precluded 
a comprehensive assessment of determinants of the inter- and intra-individual variability in the 
8-OHdG level. Only smoking was evidenced as a potential determinant of the 8-OHdG inter-
individual variability, and only when immunochemical analysis were used. To our knowledge, 
this is the first meta-analysis aimed at determining reference values for 8-OHdG in EBC. Values 
determined in this study should be considered preliminary, as they are based on a limited 
number of studies, mostly of moderate to low quality of evidence. Further research effort is 
necessary to standardize EBC sampling, storage and analytical methods. Such a standardization 
would enable an accurate estimation of the reference ranges of the 8-OHdG and potentially 
other biomarkers measurable in the EBC, which are essential for a meaningful interpretation of 
the biomonitoring results.  
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Figure 1. Flow-shart of study selection 
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Records after duplicates removed  
(n =11 867) 
Records screened on EBC  
(n = 893) 
Records excluded 
Non English language (n=1) 
No control (n=141) 
On animals (n=20) 
Blood matrix (n=19) 
Urine matrix (n=21)  
Sputum matrix (n=6) 
Bronchoalveolar lavage matrix (n=1)  
In vitro (n=9) 
On children (n=62) 
Different publication type (e.g. letter 
to Editor, review, analytical method) 
(n=253) 
Different outcome (n=55) 
Duplicates (n=2) 
(n = 590) 
Full-text articles assessed for 
eligibility  
(n = 303) 
[8-OHdG (n=17) 
8-isoprostane (n=150) 
Malondialdehyde (n=78) 
H2O2 (n=118)] 
  
 
 
8-OHdG Full-text articles excluded, 
with reasons 
Different publication type (n = 8) 
No data (n=1) 
 
 8-OHdG Studies included 
in qualitative synthesis  
(n = 8) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
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Records identified through 
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collection, Embase, Central – 
Cochrane Library Wiley  
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Figure 2. Forest-plot  of the 8-OHdG levels [pg/mL] measured in the exhaled breath condensate 
according to the analytical method 
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Figure 3. Forest-plot of the 8-OHdG levels measured in the exhaled breath condensate 
according to the smoking status and analytical method 
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